350.32
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$346.00
Aprire:
$347.02
Volume 24 ore:
1.82M
Relative Volume:
1.19
Capitalizzazione di mercato:
$67.96B
Reddito:
$321.33B
Utile/perdita netta:
$1.57B
Rapporto P/E:
44.06
EPS:
7.9518
Flusso di cassa netto:
$3.21B
1 W Prestazione:
+3.70%
1M Prestazione:
-3.21%
6M Prestazione:
+18.54%
1 anno Prestazione:
+50.84%
Cencora Inc Stock (COR) Company Profile
Nome
Cencora Inc
Settore
Industria
Telefono
610-727-7000
Indirizzo
1 WEST FIRST AVENUE, CONSHOHOCKEN
Confronta COR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
COR
Cencora Inc
|
350.32 | 67.12B | 321.33B | 1.57B | 3.21B | 7.9518 |
|
MCK
Mckesson Corporation
|
823.01 | 100.44B | 387.09B | 4.23B | 6.01B | 32.12 |
|
CAH
Cardinal Health Inc
|
199.96 | 47.09B | 234.31B | 1.61B | 4.45B | 6.6243 |
|
HSIC
Henry Schein Inc
|
77.39 | 9.01B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.21 | 741.42M | 2.22M | -5.63M | -1.68M | -0.24 |
Cencora Inc Stock (COR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-06-03 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-12-04 | Ripresa | Mizuho | Outperform |
| 2024-09-18 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2024-01-03 | Iniziato | Barclays | Overweight |
| 2023-12-14 | Iniziato | Wells Fargo | Equal Weight |
| 2023-03-31 | Iniziato | Citigroup | Buy |
| 2023-01-31 | Ripresa | Evercore ISI | Outperform |
| 2022-10-11 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-08-22 | Ripresa | Morgan Stanley | Equal-Weight |
| 2022-07-11 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-06-07 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2022-05-26 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2022-04-12 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-04-01 | Ripresa | Credit Suisse | Outperform |
| 2021-03-12 | Ripresa | Evercore ISI | In-line |
| 2021-02-04 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2021-02-02 | Aggiornamento | Cowen | Market Perform → Outperform |
| 2021-01-06 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2021-01-06 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-10 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2020-12-03 | Iniziato | Mizuho | Neutral |
| 2020-08-06 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-07-15 | Iniziato | Barclays | Underweight |
| 2020-06-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-23 | Ripresa | Credit Suisse | Outperform |
| 2020-04-16 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2020-04-13 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-04-01 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-03-17 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-02-11 | Downgrade | BofA/Merrill | Buy → Underperform |
| 2020-02-07 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2019-09-12 | Iniziato | Deutsche Bank | Hold |
| 2019-07-10 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-11 | Iniziato | Guggenheim | Buy |
| 2019-04-10 | Downgrade | BofA/Merrill | Buy → Underperform |
| 2019-04-10 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-02-11 | Downgrade | JP Morgan | Neutral → Underweight |
| 2019-01-17 | Iniziato | UBS | Buy |
| 2018-12-10 | Downgrade | Jefferies | Buy → Hold |
| 2018-10-26 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2018-09-20 | Iniziato | Berenberg | Buy |
| 2018-07-17 | Ripresa | Stifel | Hold |
| 2018-04-09 | Iniziato | MoffettNathanson | Buy |
| 2018-03-12 | Aggiornamento | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-03-12 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2017-09-25 | Iniziato | JP Morgan | Neutral |
| 2017-09-22 | Iniziato | William Blair | Outperform |
Mostra tutto
Cencora Inc Borsa (COR) Ultime notizie
Cencora to acquire full control of OneOncology in nearly $5B deal - The Business Journals
Cencora Pays $5B For Majority Stake Of OneOncology - Law360
Cencora Should See Double-Digit Long-term EPS Growth from Market Growth and Specialty Investments - Morningstar
Cencora to acquire remaining stake in OneOncology for $5 billion By Investing.com - Investing.com Nigeria
Cencora Moves To Take Full Control Of OneOncology - Finimize
Cencora to Buy Majority Stake in OneOncology for $5 billion - marketscreener.com
Cencora to buy majority of OneOncology's outstanding equity - Axios
Cencora, Inc. (COR) Announces Strategic Acquisition of OneOncolo - GuruFocus
Cencora stock price target raised to $420 from $400 at Evercore ISI - Investing.com India
Cencora backs FY26 adjusted EPS view $17.45-$17.75, consensus $17.67 - TipRanks
Cencora to take majority control of cancer care network OneOncology for $5 billion - Reuters
Evercore ISI Adjusts Price Target on Cencora to $420 From $400, Maintains Outperform Rating - marketscreener.com
Cencora, Inc. entered into a definitive agreement to acquire an additional 60% stake in OneOncology, LLC from TPG Inc. and other shareholders for approximately $5 billion. - marketscreener.com
Fitch Affirms Cencora's 'A-'/'F1' Ratings; Outlook Stable - TradingView — Track All Markets
Cencora Strikes $5 Billion OneOncology Deal, Pauses Stock Buyback - Benzinga
Cencora To Acquire Majority Stake in OneOncology From TPG - citybiz
Cencora to acquire OneOncology from TPG for $6B - TipRanks
Cencora to acquire remaining stake in OneOncology for $5 billion - Investing.com
Cencora (COR) Maintains FY26 Revenue Growth Outlook Amid Acquisi - GuruFocus
Cencora Finalizes Agreement to Acquire TPG's Equity Interest in OneOncology - PR Newswire
Cencora accelerates OneOncology acquisition, extending solutions offering for community oncology - marketscreener.com
Cencora to take majority control of OneOncology to expand cancer services - TradingView — Track All Markets
Cencora to take majority control of OneOncology - marketscreener.com
MASTERINVEST Kapitalanlage GmbH Acquires Shares of 3,762 Cencora, Inc. $COR - MarketBeat
Cencora, Inc. Agrees to Acquire Majority Stake in OneOncology - TradingView — Track All Markets
Cencora (NYSE: COR) to spend $5B on OneOncology, lifts long-term EPS guide - Stock Titan
National Bank of Canada FI Buys 178,383 Shares of Cencora, Inc. $COR - MarketBeat
Caxton Associates LLP Grows Holdings in Cencora, Inc. $COR - MarketBeat
Holocene Advisors LP Has $192.88 Million Position in Cencora, Inc. $COR - MarketBeat
Should Cencora’s (COR) Cryogenic 3PL Expansion Reshape Its Role in Complex Therapies Logistics? - simplywall.st
BI Asset Management Fondsmaeglerselskab A S Grows Stock Position in Cencora, Inc. $COR - MarketBeat
Bellevue Group AG Trims Holdings in Cencora, Inc. $COR - MarketBeat
AQR Capital Management LLC Sells 544,524 Shares of Cencora, Inc. $COR - MarketBeat
How Low Can Cencora Stock Really Go? - Trefis
Earnings Recap: How strong dollar benefits Ares Commercial Real Estate Corporation 41I stockPortfolio Gains Summary & Long Hold Capital Preservation Tips - moha.gov.vn
Cencora Makes Major Bet on Global Pharma Logistics With U.S.–Europe Expansion - MyChesCo
Cencora’s Expanded Cold Chain and 3PL Network Might Change The Case For Investing In Cencora (COR) - Yahoo Finance
Cencora, Inc. $COR Shares Purchased by CIBC Asset Management Inc - MarketBeat
Farminveste's unit Alliance Healthcare sells to Cencora all of shares it held in Alloga Logifarma - marketscreener.com
The Manufacturers Life Insurance Company Raises Stock Holdings in Cencora, Inc. $COR - MarketBeat
Sei Investments Co. Boosts Stock Holdings in Cencora, Inc. $COR - MarketBeat
Cencora, Inc. $COR Shares Bought by Daiwa Securities Group Inc. - MarketBeat
Bank of Nova Scotia Has $7.74 Million Holdings in Cencora, Inc. $COR - MarketBeat
Here's Why You Should Add Cencora Stock to Your Portfolio Now - Finviz
Investment Management Corp of Ontario Reduces Stake in Cencora, Inc. $COR - MarketBeat
iSAM Funds UK Ltd Takes Position in Cencora, Inc. $COR - MarketBeat
State Street Corp Sells 6,729 Shares of Cencora, Inc. $COR - MarketBeat
Natixis Has $8.34 Million Stock Holdings in Cencora, Inc. $COR - MarketBeat
L2 Asset Management LLC Sells 15,893 Shares of Cencora, Inc. $COR - MarketBeat
JPMorgan raises Cencora (COR) price target after financial model update - MSN
Is Cencora, Inc. (COR) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Cencora Inc Azioni (COR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):